These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2883682)

  • 1. Effectivity of zotepine in refractory psychoses: possible relationship between zotepine and non-dopamine psychosis.
    Harada T; Otsuki S; Sato M; Wake A; Fujiwara Y; Kashihara K; Fukuda K
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):47-51. PubMed ID: 2883682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of zotepine in therapy-refractory psychoses. An open, multicenter study in eight psychiatric clinics].
    Harada T; Otsuki S; Fujiwara Y
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():41-4. PubMed ID: 1683339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
    Fleischhacker WW; Barnas C; Stuppäck C; Unterweger B; Hinterhuber H
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimanic effect of zotepine.
    Harada T; Otsuki S
    Clin Ther; 1986; 8(4):406-14. PubMed ID: 3089626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of clinical efficacy and pharmacological action of zotepine.
    Yamawaki S
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):4-7. PubMed ID: 2883681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
    Higashi Y; Momotani Y; Suzuki E; Kaku T
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with the neuroleptic zotepine--first results.
    Haug HJ
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial].
    Müller-Spahn F; Dieterle D; Ackenheil M
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():30-5. PubMed ID: 1683337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety evaluation of zotepine for the treatment of schizophrenia.
    Riedel M; Musil R; Seemüller F; Spellmann I; Möller HJ; Schennach-Wolff R
    Expert Opin Drug Saf; 2010 Jul; 9(4):659-66. PubMed ID: 20486863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile.
    Needham PL; Atkinson J; Skill MJ; Heal DJ
    Psychopharmacol Bull; 1996; 32(1):123-8. PubMed ID: 8927661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H; von Bardeleben U; Holsboer F; Benkert O
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study.
    Meyer-Lindenberg A; Gruppe H; Bauer U; Lis S; Krieger S; Gallhofer B
    Pharmacopsychiatry; 1997 Mar; 30(2):35-42. PubMed ID: 9131723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and tolerance of zotepine in a double-blind comparison with perazine in schizophrenic patients].
    Dieterle DM; Müller-Spahn F; Ackenheil M
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():18-22. PubMed ID: 1683334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three cases of alopecia areata induced by zotepine.
    Kubota T; Ishikura T; Jibiki I
    Acta Neurol (Napoli); 1993 Jun; 15(3):200-3. PubMed ID: 7901970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.